» Articles » PMID: 24457952

Long Non-coding RNA UCA1 Promotes Breast Tumor Growth by Suppression of P27 (Kip1)

Overview
Journal Cell Death Dis
Date 2014 Jan 25
PMID 24457952
Citations 213
Authors
Affiliations
Soon will be listed here.
Abstract

Functional genomics studies have led to the discovery of a large amount of non-coding RNAs from the human genome; among them are long non-coding RNAs (lncRNAs). Emerging evidence indicates that lncRNAs could have a critical role in the regulation of cellular processes such as cell growth and apoptosis as well as cancer progression and metastasis. As master gene regulators, lncRNAs are capable of forming lncRNA-protein (ribonucleoprotein) complexes to regulate a large number of genes. For example, lincRNA-RoR suppresses p53 in response to DNA damage through interaction with heterogeneous nuclear ribonucleoprotein I (hnRNP I). The present study demonstrates that hnRNP I can also form a functional ribonucleoprotein complex with lncRNA urothelial carcinoma-associated 1 (UCA1) and increase the UCA1 stability. Of interest, the phosphorylated form of hnRNP I, predominantly in the cytoplasm, is responsible for the interaction with UCA1. Moreover, although hnRNP I enhances the translation of p27 (Kip1) through interaction with the 5'-untranslated region (5'-UTR) of p27 mRNAs, the interaction of UCA1 with hnRNP I suppresses the p27 protein level by competitive inhibition. In support of this finding, UCA1 has an oncogenic role in breast cancer both in vitro and in vivo. Finally, we show a negative correlation between p27 and UCA in the breast tumor cancer tissue microarray. Together, our results suggest an important role of UCA1 in breast cancer.

Citing Articles

Identification of urothelial cancer-associated 1 (UCA1) as a diagnostic biomarker of pre-eclampsia via regulating microRNA-16 and its downstream signaling pathway.

Xv Y, Gao W, Wang L Arch Med Sci. 2024; 20(5):1511-1521.

PMID: 39649283 PMC: 11623140. DOI: 10.5114/aoms/111375.


Long non-coding RNA Knockdown Assisted by CRISPR/Cas9 in Female Cancer Cell Lines Increases Mir-143 .

Montazeri-Najafabadi B, Doosti A, Kiani J Iran J Public Health. 2024; 53(4):934-946.

PMID: 39444484 PMC: 11493584. DOI: 10.18502/ijph.v53i4.15571.


Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation.

Poltronieri P Explor Target Antitumor Ther. 2024; 5(4):841-876.

PMID: 39280246 PMC: 11390297. DOI: 10.37349/etat.2024.00252.


Exosomal lncRNAs as regulators of breast cancer chemoresistance and metastasis and their potential use as biomarkers.

Blancas-Zugarazo S, Langley E, Hidalgo-Miranda A Front Oncol. 2024; 14:1419808.

PMID: 39148900 PMC: 11324554. DOI: 10.3389/fonc.2024.1419808.


The Expression Profiles of lncRNAs Are Associated with Neoadjuvant Chemotherapy Resistance in Locally Advanced, Luminal B-Type Breast Cancer.

Gonzalez-Woge M, Contreras-Espinosa L, Garcia-Gordillo J, Aguilar-Villanueva S, Bargallo-Rocha E, Cabrera-Galeana P Int J Mol Sci. 2024; 25(15).

PMID: 39125649 PMC: 11311431. DOI: 10.3390/ijms25158077.


References
1.
Izquierdo J, Majos N, Bonnal S, Martinez C, Castelo R, Guigo R . Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell. 2005; 19(4):475-84. DOI: 10.1016/j.molcel.2005.06.015. View

2.
Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

3.
Birney E, Stamatoyannopoulos J, Dutta A, Guigo R, Gingeras T, Margulies E . Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007; 447(7146):799-816. PMC: 2212820. DOI: 10.1038/nature05874. View

4.
Catzavelos C, Bhattacharya N, Ung Y, Wilson J, Roncari L, Sandhu C . Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat Med. 1997; 3(2):227-30. DOI: 10.1038/nm0297-227. View

5.
Wander S, Zhao D, Slingerland J . p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin Cancer Res. 2010; 17(1):12-8. PMC: 3017239. DOI: 10.1158/1078-0432.CCR-10-0752. View